Gelmon K - Search Results

1

Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study.

Yerushalmi R, Kramer MR, Rizel S, Sulkes A, Gelmon K, Granot T, Neiman V, Stemmer SM. Yerushalmi R, et al. Among authors: gelmon k. Ann Oncol. 2009 Mar;20(3):437-40. doi: 10.1093/annonc/mdn652. Epub 2009 Jan 12. Ann Oncol. 2009. PMID: 19139179 Free article.

2

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer.

Landman Y, Stemmer SM, Sulkes A, Neiman V, Granot T, Hendler D, Kramer MR, Gelmon K, Yerushalmi R. Landman Y, et al. Among authors: gelmon k. J Oncol. 2019 Oct 28;2019:2584859. doi: 10.1155/2019/2584859. eCollection 2019. J Oncol. 2019. PMID: 31772578 Free PMC article.

3

Metastatic behavior of breast cancer subtypes.

Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K. Kennecke H, et al. Among authors: gelmon k. J Clin Oncol. 2010 Jul 10;28(20):3271-7. doi: 10.1200/JCO.2009.25.9820. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498394

4

Chemotherapy for oestrogen-receptor-negative breast cancer.

Yerushalmi R, Gelmon K. Yerushalmi R, et al. Among authors: gelmon k. Lancet. 2008 Jan 5;371(9606):4-5. doi: 10.1016/S0140-6736(08)60043-4. Lancet. 2008. PMID: 18177755 No abstract available.

5

Patterns of relapse in breast cancer: changes over time.

Yerushalmi R, Woods R, Kennecke H, Speers C, Knowling M, Gelmon K. Yerushalmi R, et al. Among authors: gelmon k. Breast Cancer Res Treat. 2010 Apr;120(3):753-9. doi: 10.1007/s10549-009-0510-2. Epub 2009 Aug 22. Breast Cancer Res Treat. 2010. PMID: 19701704

6

Breast Cancer Subtype Variation by Race and Ethnicity in a Diverse Population in British Columbia.

Wan D, Villa D, Woods R, Yerushalmi R, Gelmon K. Wan D, et al. Among authors: gelmon k. Clin Breast Cancer. 2016 Jun;16(3):e49-55. doi: 10.1016/j.clbc.2015.09.005. Epub 2015 Sep 25. Clin Breast Cancer. 2016. PMID: 26454611

7

Treatment beyond progression: is it moving from belief to evidence?

Yerushalmi R, Gelmon K. Yerushalmi R, et al. Among authors: gelmon k. Oncologist. 2010;15(8):796-8. doi: 10.1634/theoncologist.2010-0137. Epub 2010 Jul 29. Oncologist. 2010. PMID: 20671106 Free PMC article.

8

Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.

Lohrisch C, Paltiel C, Gelmon K, Speers C, Taylor S, Barnett J, Olivotto IA. Lohrisch C, et al. Among authors: gelmon k. J Clin Oncol. 2006 Oct 20;24(30):4888-94. doi: 10.1200/JCO.2005.01.6089. Epub 2006 Oct 2. J Clin Oncol. 2006. PMID: 17015884

9

Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.

Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K, Yasui Y, McKenzie DC. Courneya KS, et al. Among authors: gelmon k. J Clin Oncol. 2007 Oct 1;25(28):4396-404. doi: 10.1200/JCO.2006.08.2024. Epub 2007 Sep 4. J Clin Oncol. 2007. PMID: 17785708 Clinical Trial.

10

Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.

Chia S, Clemons M, Martin LA, Rodgers A, Gelmon K, Pond GR, Panasci L. Chia S, et al. Among authors: gelmon k. J Clin Oncol. 2006 Jun 20;24(18):2773-8. doi: 10.1200/JCO.2005.03.8331. Epub 2006 May 8. J Clin Oncol. 2006. PMID: 16682726 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters